Literature DB >> 29993127

Biochemical and structural insights into an allelic variant causing the lysosomal storage disorder - aspartylglucosaminuria.

Suchita Pande1, William Bizilj1, Hwai-Chen Guo1.   

Abstract

Aspartylglucosaminuria (AGU) is a lysosomal storage disorder caused by defects of the hydrolase glycosylasparaginase (GA). Previously, we showed that a Canadian AGU mutation disrupts an obligatory intramolecular autoprocessing with the enzyme trapped as an inactive precursor. Here, we report biochemical and structural characterizations of a model enzyme corresponding to a Finnish AGU allele, the T234I variant. Unlike the Canadian counterpart, the Finnish variant is capable of a slow autoprocessing to generate detectible hydrolyzation activity of the natural substrate of GA. We have determined a 1.6 Å-resolution structure of the Finnish AGU model and built an enzyme-substrate complex to provide a structural basis for analyzing the negative effects of the point mutation on KM and kcat of the mature enzyme. ENZYME: Glycosylasparaginase or aspartylglucosaminidase, EC3.5.1.26.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  aspartylglucosaminuria; autoprocessing; autoproteolysis; crystal structure; glycosylasparaginase; kinetic characterization

Mesh:

Substances:

Year:  2018        PMID: 29993127      PMCID: PMC6119092          DOI: 10.1002/1873-3468.13190

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  36 in total

1.  Structural insights into the mechanism of intramolecular proteolysis.

Authors:  Q Xu; D Buckley; C Guan; H C Guo
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

Review 2.  Protein splicing and related forms of protein autoprocessing.

Authors:  H Paulus
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

3.  Aspartylglucosaminuria: unusual neonatal presentation in Qatari twins with a novel aspartylglucosaminidase gene mutation and 3 new cases in a Turkish family.

Authors:  Thomas Opladen; Friedrich Ebinger; Johannes Zschocke; Devjani Sengupta; Tawfeg Ben-Omran; Noora Shahbeck; Ute Moog; Christine Fischer; Friederike Bürger; Dorothea Haas; Peter Ruef; Inga Harting; Hilal Al-Rifai; Georg F Hoffmann
Journal:  J Child Neurol       Date:  2012-12-26       Impact factor: 1.987

4.  Characterization and functional analysis of the cis-autoproteolysis active center of glycosylasparaginase.

Authors:  C Guan; Y Liu; Y Shao; T Cui; W Liao; A Ewel; R Whitaker; H Paulus
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

5.  Breaking up is easy with esters.

Authors:  F B Perler
Journal:  Nat Struct Biol       Date:  1998-04

6.  Purification and characterization of rat liver glycosylasparaginase.

Authors:  O K Tollersrud; N N Aronson
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

7.  Autoproteolytic activation of human aspartylglucosaminidase.

Authors:  Jani Saarela; Carita Oinonen; Anu Jalanko; Juha Rouvinen; Leena Peltonen
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

8.  Accumulation of glycoprotein-derived metabolites in neural and visceral tissue in aspartylglycosaminuria.

Authors:  C P Maury
Journal:  J Lab Clin Med       Date:  1980-11

9.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria.

Authors:  Antje Banning; Christina Gülec; Juha Rouvinen; Steven J Gray; Ritva Tikkanen
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

View more
  2 in total

1.  The T99K variant of glycosylasparaginase shows a new structural mechanism of the genetic disease aspartylglucosaminuria.

Authors:  Suchita Pande; Hwai-Chen Guo
Journal:  Protein Sci       Date:  2019-04-09       Impact factor: 6.725

Review 2.  Modeling Rare Human Disorders in Mice: The Finnish Disease Heritage.

Authors:  Tomáš Zárybnický; Anne Heikkinen; Salla M Kangas; Marika Karikoski; Guillermo Antonio Martínez-Nieto; Miia H Salo; Johanna Uusimaa; Reetta Vuolteenaho; Reetta Hinttala; Petra Sipilä; Satu Kuure
Journal:  Cells       Date:  2021-11-13       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.